Logo image
An empirical examination of appetite hormones and cognitive and behavioral bulimic symptomatology
Journal article   Open access   Peer reviewed

An empirical examination of appetite hormones and cognitive and behavioral bulimic symptomatology

Emily K Presseller, Kelsey E Clark, Caroline Fojtu and Adrienne S Juarascio
Eating and weight disorders, v 26(4), pp 1129-1137
May 2021
PMID: 32951131
url
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8095371View
Accepted (AM)Open Access (License Unspecified) Open

Abstract

Binge eating Neuroendocrinology Appetite hormones Bulimia nervosa
Existing literature has demonstrated that appetite hormones are frequently dysregulated in individuals with bulimic-spectrum eating disorders (BN-EDs). Although dysregulations in appetite hormones may maintain BN-EDs, very limited research has examined the association between dysregulated appetite hormones and cognitive and behavioral bulimic symptoms. We hypothesized that greater frequency of behavioral symptoms and severity of cognitive symptoms of BN-EDs would correlate with greater dysregulation in appetite hormones. The association between ghrelin, cortisol, leptin, GLP-1, and amylin levels and eating pathology was examined in treatment-seeking adults with BN-EDs (N = 33). Participants completed bloodwork to assess fasting blood hormone levels and bulimic symptoms were measured by the Eating Disorder Examination. Pearson partial correlations were run to examine the association between hormone levels and eating pathology, controlling for BMI. Contrary to hypotheses, none of the appetite hormones tested were significantly associated with frequency of behavioral ED symptoms (p range = 0.13-0.97, negligible to small effect sizes). Global eating pathology was positively associated with leptin (p = 0.03) and negatively associated with GLP-1 (p = 0.03) and amylin (p = 0.04), with medium effect sizes. Post hoc analyses indicated significantly stronger associations between appetite hormones and cognitive eating pathology than between appetite hormones and frequency of binge eating [GLP-1 (p = 0.02) and amylin (p = 0.02)] or compensatory behaviors [leptin (p = 0.03), GLP-1 (p = 0.02), and amylin (p = 0.04)]. In individuals with BN-EDs, appetite hormones may be more strongly associated with cognitive symptoms than behavioral symptoms. Level V, cross-sectional descriptive study.

Metrics

16 Record Views
3 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being
#5 Gender Equality

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Web of Science research areas
Psychiatry
Logo image